Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Fibroblast growth factor 23 (FGF23)"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
PurposeErythrodermic psoriasis (EP) is a severe form of psoriasis that affects multiple organs, including the cardiovascular system. However, few studies have focused on this condition.This study is aimed to assess the prevalence and factors associat
Externí odkaz:
https://doaj.org/article/f160a6fdf32444d28493fb369cab06bc
Autor:
Toshihiro Tajima, Yukihiro Hasegawa
Publikováno v:
Endocrines, Vol 3, Iss 3, Pp 522-529 (2022)
The conventional treatment for X-linked hypophosphatemia (XLH), consisting of phosphorus supplementation and a biologically active form of vitamin D (alfacalcidol or calcitriol), is used to treat rickets and leg deformities and promote growth. Howeve
Externí odkaz:
https://doaj.org/article/45ae3a522d064cbd9458b2e9d82d4b19
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Diabetic kidney disease (DKD) causes the greatest proportion of end-stage renal disease (ESRD)–related mortality and has become a high concern in patients with diabetes mellitus (DM). Bone is considered an endocrine organ, playing an emerging role
Externí odkaz:
https://doaj.org/article/4805bcda95e24b68b8c6fbe09a80f870
Publikováno v:
Otolaryngology Case Reports, Vol 23, Iss , Pp 100407- (2022)
Background: phosphaturic mesenchymal tumor (PMT) is a rare neoplasm in which the tumor cells produce fibroblast growth factor 23 (FGF23), leading to oncogenic osteomalacia and thus a distinct clinical presentation. Case presentation: A 39-year-old ma
Externí odkaz:
https://doaj.org/article/7749f618f9784224864f5e85a7e0e499
Publikováno v:
Frontiers in Dental Medicine, Vol 3 (2022)
Hypophosphatasia is a rare heritable metabolic disorder caused by deficient Tissue Non-specific Alkaline Phosphatase (TNAP) enzyme activity. A principal function of TNAP is to hydrolyze the tissue mineralization inhibitor pyrophosphate. ENPP1 (Ectonu
Externí odkaz:
https://doaj.org/article/13c32af1e7d047dea6b7ad358ec3eb5d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Signe Sparre Beck-Nielsen, Zulf Mughal, Dieter Haffner, Ola Nilsson, Elena Levtchenko, Gema Ariceta, Carmen de Lucas Collantes, Dirk Schnabel, Ravi Jandhyala, Outi Mäkitie
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-25 (2019)
Abstract Background X-linked hypophosphatemia (XLH) is an inherited disease of phosphate metabolism in which inactivating mutations of the Phosphate Regulating Endopeptidase Homolog, X-Linked (PHEX) gene lead to local and systemic effects including i
Externí odkaz:
https://doaj.org/article/acfb5f3933a643098455d783b398c950
Autor:
Alisa E Lee, Emily Y Chu, Pamela J Gardner, Olivier Duverger, Amanda Saikali, Sean K Wang, Rachel I Gafni, Iris R Hartley, Kelly G Ten Hagen, Martha J Somerman, Michael T Collins
Publikováno v:
JBMR Plus, Vol 5, Iss 5, Pp n/a-n/a (2021)
ABSTRACT Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare autosomal recessive disorder caused by mutations in FGF23, GALNT3, KLOTHO, or FGF23 autoantibodies. Prominent features include high blood phosphate and calcific masses, usually a
Externí odkaz:
https://doaj.org/article/269e9f264f124907a0616bffd3364a0f
Autor:
Michaël R. Laurent, Jean De Schepper, Dominique Trouet, Nathalie Godefroid, Emese Boros, Claudine Heinrichs, Bert Bravenboer, Brigitte Velkeniers, Johan Lammens, Pol Harvengt, Etienne Cavalier, Jean-François Kaux, Jacques Lombet, Kathleen De Waele, Charlotte Verroken, Koenraad van Hoeck, Geert R. Mortier, Elena Levtchenko, Johan Vande Walle
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
X-linked hypophosphatemia (XLH) is the most common genetic form of hypophosphatemic rickets and osteomalacia. In this disease, mutations in the PHEX gene lead to elevated levels of the hormone fibroblast growth factor 23 (FGF23), resulting in renal p
Externí odkaz:
https://doaj.org/article/6cceeed2dd894287b3e26629039907bc